Literature DB >> 8907586

Evaluation of the effects of defensins on neutrophil functions.

S Yomogida1, I Nagaoka, K Saito, T Yamashita.   

Abstract

Defensins are known to be the microbicidal components of neutrophil granules, which contribute to oxygen-independent antimicrobial mechanisms. In this study, we have examined the effect of defensins on neutrophil functions, such as adhesion, superoxide anion generation, phagocytosis and chemotaxis. Guinea-pig defensins increased the expression of CD11b, CD11c and CD54 (intercellular adhesion molecule ICAM-1) on human neutrophils, and induced adhesion of guinea-pig and human neutrophils. When the effect of guinea-pig defensins on superoxide anion generation was examined, defensins inhibited superoxide anion generation during phagocytosis of complement-opsonized particles. Furthermore, defensins inhibited complement-dependent phagocytosis. However, they did not inhibit the binding of complement-opsonized particles to neutrophils, suggesting that defensins possibly inhibit complement-dependent phagocytosis by affecting the ingestion step but not the binding step. Defensins exhibited neither chemotactic nor chemokine activity. Interestingly, 10-20% of total defensins were released extracellularly from phagocytosing neutrophils. Together these observations indicate that, in addition to their antimicrobial activity, defensins may have the ability to modulate the functions of neutrophils at sites of infection or inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8907586     DOI: 10.1007/bf02265117

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  22 in total

Review 1.  Antibiotic proteins of human neutrophils.

Authors:  J K Spitznagel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

3.  Monocyte-chemotactic activity of defensins from human neutrophils.

Authors:  M C Territo; T Ganz; M E Selsted; R Lehrer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Membrane glycoprotein p150,95 of human cytotoxic T cell clone is involved in conjugate formation with target cells.

Authors:  G D Keizer; J Borst; W Visser; R Schwarting; J E de Vries; C G Figdor
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

5.  Selective inhibition by the sulfhydryl reagent maleimide of zymosan particle phagocytosis by neutrophils.

Authors:  T Yamashita
Journal:  FEBS Lett       Date:  1982-05-03       Impact factor: 4.124

Review 6.  Defensins.

Authors:  T Ganz; M E Selsted; R I Lehrer
Journal:  Eur J Haematol       Date:  1990-01       Impact factor: 2.997

7.  Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides.

Authors:  T Yamashita; K Saito
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

8.  Effect of maleimide derivatives on superoxide-generating system of guinea-pig neutrophils stimulated by different soluble stimuli.

Authors:  T Yamashita; A Someya; Y Tsuzawa-Kido
Journal:  Eur J Biochem       Date:  1984-11-15

Review 9.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Authors:  R I Lehrer; A K Lichtenstein; T Ganz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils.

Authors:  C Nathan; E Sanchez
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

View more
  8 in total

1.  Defensins impair phagocytic killing by neutrophils in biomaterial-related infection.

Authors:  S S Kaplan; R P Heine; R L Simmons
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Dynamic changes in neutrophil defensins during endotoxemia.

Authors:  M E Klut; B A Whalen; J C Hogg
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

4.  Immunohistochemical localization of defensin in human coronary vessels.

Authors:  E S Barnathan; P N Raghunath; J E Tomaszewski; T Ganz; D B Cines
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process.

Authors:  Akimasa Someya; Joel Moss; Isao Nagaoka
Journal:  J Biol Chem       Date:  2010-07-02       Impact factor: 5.157

6.  Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils.

Authors:  François Niyonsaba; Hideoki Ogawa; Isao Nagaoka
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

7.  Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes.

Authors:  P S Grutkoski; C T Graeber; Y P Lim; A Ayala; H H Simms
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 8.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.